Evidence map›Paper›PMID 29565100›Full record

ArticleRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia2018

Clinical and microbiologic characteristics of pleuro-pulmonary infection due to Streptococcus intermedius.

F Cobo, A Sampedro, J Rodríguez-Granger, L Aliaga-Martínez, J M Navarro-Marí

Open access · greenAbstract read
In one paragraph

Article in Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Frontiers in medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Infectious disease reports · 2023
    Article
  6. Clinical features ofFrontiers in microbiology · 2023
    Article
  7. Empyema in a Patient with Schizophrenia Using Clozapine: A Case Report.Psychiatry and clinical psychopharmacology · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

F CoboFernando Cobo, Department of Microbiology, Hospital Virgen de las Nieves Avda Fuerzas Armadas, 2 18014 Granada, Spain. fernando.cobo.sspa@juntadeandalucia.es.
A Sampedro
J Rodríguez-Granger
L Aliaga-Martínez
J M Navarro-Marí
Hospital Universitario Virgen de las Nieves · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical and microbiological characteristics of pleuro-pulmonary infection (PPI) caused by Streptococcus intermedius is described, including 6 cases in the literature and 9 cases handled at the present centre. Out of the 15 patients, 12 were male; mean age at diagnosis was 62.06 ± 15 years. Twelve had risk factors for S. intermedius infection such as alcoholism in 5 (35.7%) patients, periodontal disease in 3 (24.6%) cases, chronic obstructive pulmonary disease in 3 (24.6%), and diabetes mellitus in 2 (14.2%). Cough was present in 12 (80%) patients and chest pain and dyspnea in 9 (60%). The mean diagnosis interval was 34 days. The diagnosis was obtained from pleural fluid aspirate in 13 (86.6%) cases and from biopsy/tissue samples in 2. The most frequently antimicrobials used for treatment were ceftriaxone + levofloxacin. Ten patients cured with a combination of medical and surgical treatment and 2 patients died as a consequence of infection. The incidence of PPI caused by S. intermedius is increasing in our health area; drainage along with antibiotic therapy is recommended for treatment.

Indexed as

Streptococcus intermediusAdultAgedAged, 80 and overAnti-Bacterial AgentsCombined Modality TherapyFemaleHumansIncidenceLung DiseasesMaleMiddle AgedPleural DiseasesPleural EffusionRespiratory Tract InfectionsRisk FactorsAnti-Bacterial Agents

Identifiers

PMID29565100
PMCPMC6159373
OpenAlexW2988839630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.